T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Neurocrine Biosciences
NBIX
$16.5B
| $442M | 0.08% |
7,207,373
+41,489
| +0.6% | +$2.19M |
|
277
ASML
ASML
$691B
| $442M | 0.08% |
2,579,618
+21,138
| +0.8% | +$3.24M |
|
278
Intel
INTC
$493B
| $441M | 0.08% |
11,572,530
-351,430
| -3% | -$12.5M |
|
|
HDS
279
DELISTED
HD Supply Holdings, Inc.
HDS
| $438M | 0.07% |
12,138,355
+12,052,484
| +14,036% | +$387M |
|
280
Mattel
MAT
$4.29B
| $437M | 0.07% |
28,218,305
+1,652,040
| +6% | +$29.5M |
|
281
DTE Energy
DTE
$28.6B
| $433M | 0.07% |
4,742,415
-421,936
| -8% | -$39.1M |
|
282
NRG Energy
NRG
$25.2B
| $428M | 0.07% |
16,735,471
-7,882,187
| -32% | -$186M |
|
283
Dentsply Sirona
XRAY
$2.31B
| $425M | 0.07% |
7,104,696
-4,216,945
| -37% | -$251M |
|
|
WR
284
DELISTED
Westar Energy Inc
WR
| $425M | 0.07% |
8,565,667
+4,111,906
| +92% | +$209M |
|
285
Gartner
IT
$11.8B
| $418M | 0.07% |
3,358,366
+35,262
| +1% | +$4.36M |
|
286
FirstEnergy
FE
$27.1B
| $417M | 0.07% |
13,540,759
-623,909
| -4% | -$19.6M |
|
287
Accenture
ACN
$110B
| $415M | 0.07% |
3,075,060
+184,471
| +6% | +$24M |
|
288
Essex Property Trust
ESS
$18.2B
| $412M | 0.07% |
1,623,743
-32,776
| -2% | -$8.56M |
|
|
LEXEA
289
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $410M | 0.07% |
7,726,261
+149,143
| +2% | +$8.07M |
|
|
WCG
290
DELISTED
Wellcare Health Plans, Inc.
WCG
| $407M | 0.07% |
2,371,917
-50,397
| -2% | -$8.83M |
|
291
Martin Marietta Materials
MLM
$33.3B
| $407M | 0.07% |
1,972,969
-86,071
| -4% | -$18.2M |
|
|
292
Starbucks
SBUX
$122B
| $406M | 0.07% |
7,562,044
-28,662,642
| -79% | -$1.59B |
|
293
Public Storage
PSA
$60.7B
| $406M | 0.07% |
1,896,266
-20,419
| -1% | -$4.22M |
|
294
IQVIA
IQV
$40.1B
| $403M | 0.07% |
4,238,328
+656,268
| +18% | +$60.8M |
|
295
Nucor
NUE
$61.9B
| $402M | 0.07% |
7,169,122
+858,259
| +14% | +$48.5M |
|
296
Insmed
INSM
$29B
| $401M | 0.07% |
12,859,684
+2,565,133
| +25% | +$48.9M |
|
|
NATI
297
DELISTED
National Instruments Corp
NATI
| $401M | 0.07% |
9,499,622
+1,732,117
| +22% | +$70.5M |
|
298
Southwest Airlines
LUV
$22.3B
| $400M | 0.07% |
7,148,458
+146,367
| +2% | +$8.21M |
|
299
SL Green Realty
SLG
$3.95B
| $399M | 0.07% |
4,066,266
-104,110
| -2% | -$10.1M |
|
|
MIK
300
DELISTED
Michaels Stores, Inc
MIK
| $395M | 0.07% |
18,415,632
-4,498,058
| -20% | -$91.7M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.